Danaher Schedules First Quarter 2026 Earnings Conference Call
PRNewswire (Fri, 20-Mar 4:15 PM ET)
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Thu, 12-Mar 3:47 PM ET)
Danaher Announces Quarterly Dividend
PRNewswire (Tue, 24-Feb 4:30 PM ET)
Danaher to Present at TD Cowen Health Care Conference
PRNewswire (Tue, 24-Feb 4:05 PM ET)
Business Wire (Wed, 18-Feb 8:30 PM ET)
Masimo to be Acquired by Danaher for $180.00 Per Share
Business Wire (Tue, 17-Feb 8:02 AM ET)
Danaher To Acquire Masimo Corporation
PRNewswire (Tue, 17-Feb 8:00 AM ET)
Globe Newswire (Thu, 12-Feb 12:30 PM ET)
Danaher Delivers Solid 2025 Performance, Sets Stage for Accelerated Growth in 2026
Market Chameleon (Wed, 28-Jan 3:09 AM ET)
Danaher Reports Fourth Quarter and Full Year 2025 Results
PRNewswire (Wed, 28-Jan 6:00 AM ET)
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Danaher trades on the NYSE stock market under the symbol DHR.
As of March 20, 2026, DHR stock price declined to $189.35 with 5,185,944 million shares trading.
DHR has a beta of 1.17, meaning it tends to be more sensitive to market movements. DHR has a correlation of 0.36 to the broad based SPY ETF.
DHR has a market cap of $133.90 billion. This is considered a Large Cap stock.
Last quarter Danaher reported $7 billion in Revenue and $2.23 earnings per share. This beat revenue expectation by $36 million and exceeded earnings estimates by $.06.
In the last 3 years, DHR traded as high as $281.70 and as low as $171.00.
The top ETF exchange traded funds that DHR belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
DHR has underperformed the market in the last year with a price return of -9.3% while the SPY ETF gained +15.6%. DHR has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -15.6% and -6.3%, respectively, while the SPY returned -4.7% and -4.8%, respectively.
DHR support price is $186.90 and resistance is $193.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DHR shares will trade within this expected range on the day.